Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 12 | Cellular & Molecular Biology Letters

Fig. 12

From: New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation

Fig. 12

Metformin can potentially regulate the immune-metabolic microenvironment in SCM by targeting BCS1L. A mRNA expression of potential targets in the control, SCM, and SCM–metformin groups. BD Proteins were isolated from cardiomyocytes in the control, SCM, and SCM–metformin groups, and the levels of BCS1L and FBXO7 were determined by western blotting. EK Analysis of HL-1 mitochondrial metabolism with Seahorse XFe96 Analyzer. OCR was monitored continuously at baseline and after adding oligomycin (2 mM), FCCP (1 mM), and R/A (0.5 mM) to compare basal respiration, maximal respiration, nonmitochondrial oxygen consumption, spare respiratory capacity, proton leak, and ATP production levels among the control, SCM, SCM–metformin, and SCM–metformin–siBCS1L groups. GI Comparison of levels of inflammation factors among different groups (N = 6 mice or eight independent cell samples per group). *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page